Depression is a major cause of morbidity and low quality of life among patients with cardiovascular disease (CVD), and it is now considered as an independent risk factor for major adverse cardiovascular events. Increasing evidence indicates not only that depression worsens the prognosis of cardiac events, but also that a cross-vulnerability between the two conditions occurs. Among the several mechanisms proposed to explain this interplay, platelet activation is the more attractive, seeing platelets as potential mirror of the brain function. In this review, we dissected the mechanisms linking depression and CVD highlighting the critical role of platelet behavior during depression as trigger of cardiovascular complication. In particular, we will discuss the relationship between depression and molecules involved in the CVD (e.g., catecholamines, adipokines, lipids, reactive oxygen species, and chemokines), emphasizing their impact on platelet activation and related mechanisms.
Depression and cardiovascular disease: The viewpoint of platelets / P. Amadio, M. Zara, L. Sandrini, A. Ieraci, S.S. Barbieri. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1661-6596. - 21:20(2020 Oct 13), pp. 7560.1-7560.34.
|Titolo:||Depression and cardiovascular disease: The viewpoint of platelets|
IERACI, ALESSANDRO (Penultimo)
|Parole Chiave:||Adipokines; Catecholamines; Chemokines; Depression; Low density lipoproteins; Platelets; Reactive oxygen species|
|Settore Scientifico Disciplinare:||Settore BIO/14 - Farmacologia|
Settore BIO/13 - Biologia Applicata
Settore BIO/09 - Fisiologia
|Data di pubblicazione:||13-ott-2020|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.3390/ijms21207560|
|Appare nelle tipologie:||01 - Articolo su periodico|